A growing trend among GLP-1 and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 users is microdosing.

Some of the platforms in the ranking below may offer medications (like Ozempic) that are not approved by the U.S. Food and ...

Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity. Drugs like Ozempic work by mimicking the hormone that releases insulin from your pancreas, ...

Microdosing GLP-1 drugs for weight loss is growing in popularity among Americans looking to save a little money or reduce gastrointestinal side effects. Some 12 percent of American adults are using ...

Influencers, content creators and celebrities across social media platforms are touting the benefits of GLP-1 drugs, but many of them aren't taking them in the same dosages as most weight ...

On this episode of Baseball Bar-B-Cast, Jake and Jordan are joined by Jeff Passan to talk all things MLB Trade Deadline, ...

Few products have captured public interest as fast as GLP-1 receptor-agonist weight-loss drugs. But one unforeseen consequence of their popularity has been to create what is, in effect, one of the ...

The MarketWatch News Department was not involved in the creation of this content. New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker ...

If a GLP-1 can change one brain this much, what happens when it changes 40 million? An evidence-based tour of America by 2030 ...

Add Yahoo as a preferred source to see more of our stories on Google. We asked doctors who prescribe GLP-1 medications to break down this trend and explain whether it’s worth it to consider ...